Diagnostic Testing Archives - Infectious Disease Advisor

General Infectious Disease

Positive Outcomes From an Infectious Disease Crisis

By

Peter Small, MD Chief Medical Officer, Hyfe

June 24, 2022

No crisis should go unexploited for its potential to improve health care delivery.

Nosocomial Infections

Mortality Increased for Carbapenem-Resistant Infections Diagnosed via Blood Cultures

By

Estie Mermelstein, MSN, FNP-BC

June 23, 2022

Investigators assessed factors associated with 90- and 365-day mortality among veterans infected carbapenem-resistant Acinetobacter baumanii and carbapenem-resistant Pseudonomas aeruginosa.

HIV/AIDS

Vectored Immunoprophylaxis May Be a Valuable Tool in the Fight Against HIV/AIDS

By

Estie Mermelstein, MSN, FNP-BC

June 21, 2022

Researchers assessed whether adeno-associated virus vectored immunoprophylaxis with AAV8-VRC07 produces broadly neutralizing antibodies in patients with HIV.

Heart rate monitor in an intensive care unit.

Sepsis

Kidney Stress Biomarkers May Improve Severity Grading in Acute Kidney Injury

By

Natasha Persaud

June 21, 2022

Tissue inhibitor of metalloproteinases 2 (TIMP-2) and insulinlike growth factor binding protein 7 (IGFBP7) could be used for AKI staging.

Vector-borne Illnesses

Gaps Remain in Diagnostic Surveillance of Lyme, Other Tick-Borne Diseases

By

Maria Arini Lopez, PT, DPT, CSCS, CMTPT

June 16, 2022

Researchers assessed diagnostic testing patterns among patients with suspected tick-borne diseases in North Carolina.

Hepatitis

CD4 T-Cells Do Not Predict Outcomes of Hepatitis C Treatment in Patients With Cancer

By

Estie Mermelstein, MSN, FNP-BC

June 15, 2022

Researchers assessed whether CD4+ T-cell count predicts treatment outcomes in patients with cancer who received direct-acting antivirals for hepatitis C.

COVID19

COVID-19 Transmission Is Unlikely From Contaminated Surfaces

By

Jessica Nye, PhD

June 10, 2022

Researchers assessed the potential for COVID-19 transmission via contaminated surfaces.

COVID19

Effects of Sofosbuvir/Ledipasvir vs Nitazoxanide on COVID-19 Viral Clearance

By

Bradley van Paridon

June 9, 2022

Researchers assessed the effects of sofosbuvir/ledipasvir vs nitazoxanide when added to standard care for the treatment of mild to moderate COVID-19.

COVID19

Lung Abnormalities Identified on Hp-XeMRI in Nonhospitalized Long COVID Patients

June 6, 2022

Specialized imaging shows that posthospitalized COVID-19 patients and nonhospitalized patients with post-COVID-19 condition have lung abnormalities.

COVID19

Liver Test Abnormalities in Patients With COVID-19 Not Associated With Cytokine Storm

By

Maria Arini Lopez, PT, DPT, CSCS, CMTPT

June 2, 2022

Researchers evaluated liver test abnormalities in patients hospitalized with COVID-19 and assessed cytokine levels in individuals with vs without abnormal test results.